Gamma-Glutamyl Transferase Plus Carcinoembryonic Antigen Ratio Index: A Promising Biomarker Associated with Treatment Response to Neoadjuvant Chemotherapy for Patients with Colorectal Cancer Liver Metastases
The GCR index serves as a predictive biomarker for the efficacy of NAC in CRLM, providing a valuable clinical reference for the prognostic assessment of these patients.
Authors
- Xu Che (ORCID: https://orcid.org/0009-0000-5508-9514)
- Xinyu Bi
- Zhiyu Li (ORCID: https://orcid.org/0000-0001-6492-9511)
- Zhicheng Wei (ORCID: https://orcid.org/0000-0002-4923-1585)
- Yanjiang Yin (ORCID: https://orcid.org/0000-0002-7033-5899)
- Bowen Xu (ORCID: https://orcid.org/0000-0003-2963-9089)
- Jianping Chang
- Jianqiang Cai
Institutions
- Shandong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Current Oncology
- Published
- 2025-02-18
- DOI
- https://doi.org/10.3390/curroncol32020117
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanming Project of Medicine in Shenzhen